Mycoplasma infection and COVID-19 - red flags of diagnosis and treatment

Respiratory mycoplasmosis and chlamydia in combination with COVID-19 in children during the pandemic is a significant concern in the structure of infectious morbidity. Objective . The aim of the work is to identify the features of the course of COVID-19 in combination with atypical pathogens. Materials and methods . The work uses an integrated approach to analyzing data from clinical, laboratory and instrumental examinations in children with a combination of COVID-19 with respiratory mycoplasmosis in comparison with monoinfection groups based on the use of mathematical modeling. Results . Since the studied groups demonstrated homogeneity in most characteristics, a mathematical model for predicting the risk of combined infections was developed based on the use of a variety of clinical and laboratory data. Conclusions . Due to the high prevalence of pneumonia in children with a combination of COVID-19 with respiratory mycoplasmosis, the similarity of the key symptoms in comparison with monoinfection, an algorithm for early differential diagnosis of COVID-19 combinations with atypical pathogens has been developed based on the use of mathematical modeling for early identification of these infections at the prehospital stage.